Qingzhi Lv

901 total citations
22 papers, 730 citations indexed

About

Qingzhi Lv is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Qingzhi Lv has authored 22 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biomaterials, 10 papers in Biomedical Engineering and 6 papers in Molecular Biology. Recurrent topics in Qingzhi Lv's work include Nanoparticle-Based Drug Delivery (13 papers), Nanoplatforms for cancer theranostics (9 papers) and Advancements in Transdermal Drug Delivery (3 papers). Qingzhi Lv is often cited by papers focused on Nanoparticle-Based Drug Delivery (13 papers), Nanoplatforms for cancer theranostics (9 papers) and Advancements in Transdermal Drug Delivery (3 papers). Qingzhi Lv collaborates with scholars based in China, Montenegro and United States. Qingzhi Lv's co-authors include Zhonggui He, Houli Li, Guangxi Zhai, Zhimei Song, Aihua Yu, Jing Cui, Fengliang Cao, Yanwei Xi, Menglin Wang and Bingjun Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Chemical Engineering Journal.

In The Last Decade

Qingzhi Lv

22 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingzhi Lv China 15 283 227 207 205 104 22 730
A. Yekta Özer Türkiye 19 265 0.9× 244 1.1× 293 1.4× 123 0.6× 89 0.9× 47 795
Dima Khater Jordan 7 240 0.8× 446 2.0× 352 1.7× 247 1.2× 39 0.4× 12 1.1k
Madhu Verma India 13 175 0.6× 228 1.0× 181 0.9× 270 1.3× 26 0.3× 44 823
Mahira Zeeshan Pakistan 15 145 0.5× 170 0.7× 213 1.0× 206 1.0× 58 0.6× 21 675
Jilai Tian China 16 201 0.7× 245 1.1× 155 0.7× 94 0.5× 44 0.4× 32 720
Xue Ke China 17 314 1.1× 318 1.4× 354 1.7× 132 0.6× 60 0.6× 34 885
Muhammad Muzamil Khan Pakistan 19 296 1.0× 416 1.8× 409 2.0× 198 1.0× 39 0.4× 36 968
Somayeh Handali Iran 15 226 0.8× 275 1.2× 372 1.8× 146 0.7× 35 0.3× 28 735
Nusrat Chowdhury United States 15 131 0.5× 233 1.0× 152 0.7× 129 0.6× 42 0.4× 20 543
G. S. Vinod Kumar India 16 173 0.6× 261 1.1× 405 2.0× 146 0.7× 70 0.7× 42 823

Countries citing papers authored by Qingzhi Lv

Since Specialization
Citations

This map shows the geographic impact of Qingzhi Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingzhi Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingzhi Lv more than expected).

Fields of papers citing papers by Qingzhi Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingzhi Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingzhi Lv. The network helps show where Qingzhi Lv may publish in the future.

Co-authorship network of co-authors of Qingzhi Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Qingzhi Lv. A scholar is included among the top collaborators of Qingzhi Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingzhi Lv. Qingzhi Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Zimeng, Hengzhi Liu, Hengzhi Liu, et al.. (2025). Temporally programmed STING nanoadjuvant delivery unlocks synergistic chemotherapy-induced antitumor immunity. Science Advances. 11(29). eadw0797–eadw0797. 1 indexed citations
2.
Ma, Mengyao, Ximu Li, X. Li, et al.. (2025). Galloylated Toll-Like Receptor 7/8 Agonist Nanovaccine for Enhanced Tumor Antigen Delivery in Personalized Immunotherapy. ACS Nano. 19(12). 11900–11912. 4 indexed citations
3.
Zhang, Baoyue, Jiang Yu, Fanlin Meng, et al.. (2024). Iron ion driven remote loading of galloylated cabazitaxel prodrugs for synergistic ferroptosis and chemotherapy. Materials Today Nano. 29. 100551–100551. 3 indexed citations
4.
Yu, Jiang, Baoyue Zhang, Jinbo Li, et al.. (2024). “Transforming enemy into friend” strategy-based stimuli responsive dual-drug liposomes for synergistic chemo-photodynamic therapy. Chemical Engineering Journal. 487. 150526–150526. 22 indexed citations
5.
Lin, Ziqi, Yuequan Wang, Wenwen Li, et al.. (2024). A natural compound-empowered podophyllotoxin prodrug nanoassembly magnifies efficacy-toxicity benefits in cancer chemotherapy. Asian Journal of Pharmaceutical Sciences. 19(4). 100892–100892. 10 indexed citations
6.
Li, Guanting, Shuwen Fu, Xuanbo Zhang, et al.. (2023). Smart stimuli-responsive carrier-free nanoassembly of SN38 prodrug as efficient chemotherapeutic nanomedicine. SHILAP Revista de lepidopterología. 2(1). 20 indexed citations
7.
Liu, Tian, Danping Wang, Xiyan Wang, et al.. (2023). The effect of lengths of branched-chain fatty alcohols on the efficacy and safety of docetaxel-prodrug nanoassemblies. Acta Pharmaceutica Sinica B. 14(3). 1400–1411. 18 indexed citations
8.
Zuo, Shiyi, Danping Wang, Wenxiao Li, et al.. (2023). Cabazitaxel prodrug nanoassemblies with branched chain modifications: Narrowing the gap between efficacy and safety. Journal of Controlled Release. 360. 784–795. 20 indexed citations
9.
Tian, Baocheng, et al.. (2023). GSH-Responsive Prodrug Nanoassembly as a Carrier-Free Nanoplatform for Tumor-Targeting Delivery and Chemo-Photothermal Therapy. Molecular Pharmaceutics. 20(8). 4210–4218. 4 indexed citations
10.
Wang, Yingli, Jiang Yu, Dan Li, et al.. (2021). Paclitaxel derivative-based liposomal nanoplatform for potentiated chemo-immunotherapy. Journal of Controlled Release. 341. 812–827. 43 indexed citations
11.
Li, Keke, Wei Hong, Qingzhi Lv, et al.. (2021). Cell penetrating peptide TAT-functionalized liposomes for efficient ophthalmic delivery of flurbiprofen: Penetration and its underlying mechanism, retention, anti-inflammation and biocompatibility. International Journal of Pharmaceutics. 598. 120405–120405. 33 indexed citations
12.
Yang, Zimeng, et al.. (2020). Improved antitumor activity and tolerability of cabazitaxel derived remote-loading liposomes. International Journal of Pharmaceutics. 589. 119814–119814. 15 indexed citations
13.
Gao, Shanshan, Baocheng Tian, Jingtian Han, et al.. (2019). <p>Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema</p>. International Journal of Nanomedicine. Volume 14. 6135–6150. 45 indexed citations
14.
Lv, Qingzhi, Ruoshi Zhang, Zimeng Yang, et al.. (2018). Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA–Paclitaxel Conjugate. Molecular Pharmaceutics. 15(5). 1842–1852. 36 indexed citations
15.
Lv, Qingzhi, Dun Wang, Zimeng Yang, et al.. (2018). Repurposing antitubercular agent isoniazid for treatment of prostate cancer. Biomaterials Science. 7(1). 296–306. 19 indexed citations
16.
Yang, Jincheng, Qingzhi Lv, Wei Wei, et al.. (2018). Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy. Drug Delivery. 25(1). 807–814. 25 indexed citations
17.
Lv, Qingzhi, Xiaoguang Yang, Menglin Wang, et al.. (2018). Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye–monoamine oxidase A inhibitor conjugate. Journal of Controlled Release. 279. 234–242. 38 indexed citations
18.
Shi, Yanan, Keke Li, Baocheng Tian, et al.. (2016). Oral delivery of human growth hormone: Preparation, characterization, and pharmacokinetics. Journal of Biomaterials Applications. 31(6). 851–858. 10 indexed citations
19.
Lv, Dong, Tianle Zhu, Qingzhi Lv, et al.. (2016). Effects of co-processing sewage sludge in cement kiln on NO , NH3 and PAHs emissions. Chemosphere. 159. 595–601. 39 indexed citations
20.
Lv, Qingzhi, Aihua Yu, Yanwei Xi, et al.. (2009). Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. International Journal of Pharmaceutics. 372(1-2). 191–198. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Yekta Özer Breakdown of academic impact, for papers by Dima Khater Breakdown of academic impact, for papers by Madhu Verma Breakdown of academic impact, for papers by Mahira Zeeshan Breakdown of academic impact, for papers by Jilai Tian Breakdown of academic impact, for papers by Xue Ke Breakdown of academic impact, for papers by Muhammad Muzamil Khan Breakdown of academic impact, for papers by Somayeh Handali Breakdown of academic impact, for papers by Nusrat Chowdhury Breakdown of academic impact, for papers by G. S. Vinod Kumar
Rankless by CCL
2026